Addus HomeCare (NASDAQ:ADUS) PT Raised to $118.00

Addus HomeCare (NASDAQ:ADUS) had its price objective lifted by research analysts at Bank of America from $115.00 to $118.00 in a research note issued on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Bank of America‘s target price points to a potential upside of 10.19% from the company’s previous close.

Several other research firms also recently weighed in on ADUS. Royal Bank of Canada reissued an “outperform” rating and set a $102.00 target price on shares of Addus HomeCare in a research report on Thursday, February 29th. Barclays cut shares of Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 price objective on the stock. in a research report on Tuesday, April 23rd. William Blair restated an “outperform” rating on shares of Addus HomeCare in a report on Monday, February 5th. Finally, Oppenheimer reiterated an “outperform” rating and set a $118.00 price target on shares of Addus HomeCare in a report on Tuesday, March 26th. One investment analyst has rated the stock with a sell rating and eight have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Addus HomeCare has a consensus rating of “Moderate Buy” and an average target price of $106.57.

Addus HomeCare Stock Up 2.4 %

NASDAQ ADUS opened at $107.09 on Tuesday. The stock has a 50 day moving average price of $99.03 and a 200-day moving average price of $92.71. Addus HomeCare has a one year low of $78.35 and a one year high of $107.54. The company has a market capitalization of $1.75 billion, a P/E ratio of 27.89, a P/E/G ratio of 1.94 and a beta of 0.96. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.38 and a current ratio of 1.38.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings data on Monday, May 6th. The company reported $1.21 EPS for the quarter, topping analysts’ consensus estimates of $0.97 by $0.24. The business had revenue of $280.70 million during the quarter, compared to analysts’ expectations of $279.49 million. Addus HomeCare had a net margin of 5.91% and a return on equity of 9.70%. The business’s revenue was up 11.6% on a year-over-year basis. During the same period last year, the company posted $0.84 EPS. As a group, equities analysts predict that Addus HomeCare will post 4.38 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in ADUS. Louisiana State Employees Retirement System bought a new position in shares of Addus HomeCare during the fourth quarter valued at approximately $752,000. Hsbc Holdings PLC boosted its position in Addus HomeCare by 2.9% during the 3rd quarter. Hsbc Holdings PLC now owns 41,578 shares of the company’s stock valued at $3,542,000 after acquiring an additional 1,177 shares in the last quarter. First Eagle Investment Management LLC increased its holdings in shares of Addus HomeCare by 61.6% in the 3rd quarter. First Eagle Investment Management LLC now owns 46,239 shares of the company’s stock valued at $3,939,000 after acquiring an additional 17,630 shares during the period. Cetera Trust Company N.A bought a new position in shares of Addus HomeCare in the 4th quarter worth $219,000. Finally, Vanguard Group Inc. lifted its stake in shares of Addus HomeCare by 4.9% during the 3rd quarter. Vanguard Group Inc. now owns 1,218,564 shares of the company’s stock worth $103,809,000 after purchasing an additional 57,040 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.